Intercept Pharmaceuticals, Inc. EPS - Earnings per Share 2013-2023 | ICPT
Intercept Pharmaceuticals, Inc. eps - earnings per share from 2013 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Intercept Pharmaceuticals, Inc. Annual EPS |
| 2022 |
$6.56 |
| 2021 |
$-2.87 |
| 2020 |
$-8.34 |
| 2019 |
$-10.89 |
| 2018 |
$-10.86 |
| 2017 |
$-14.38 |
| 2016 |
$-16.74 |
| 2015 |
$-9.56 |
| 2014 |
$-13.63 |
| 2013 |
$-3.76 |
| 2012 |
$-7.36 |
| 2011 |
$-4.73 |
| 2010 |
$-5.40 |
| Intercept Pharmaceuticals, Inc. Quarterly EPS |
| 2023-09-30 |
$-0.07 |
| 2023-06-30 |
$-0.14 |
| 2023-03-31 |
$-0.77 |
| 2022-12-31 |
$-0.41 |
| 2022-09-30 |
$7.80 |
| 2022-06-30 |
$-0.25 |
| 2022-03-31 |
$-0.58 |
| 2021-12-31 |
$-1.21 |
| 2021-09-30 |
$-0.11 |
| 2021-06-30 |
$-0.33 |
| 2021-03-31 |
$-1.22 |
| 2020-12-31 |
$-1.55 |
| 2020-09-30 |
$-2.01 |
| 2020-06-30 |
$-1.92 |
| 2020-03-31 |
$-2.86 |
| 2019-12-31 |
$-2.99 |
| 2019-09-30 |
$-2.59 |
| 2019-06-30 |
$-2.28 |
| 2019-03-31 |
$-3.03 |
| 2018-12-31 |
$-2.88 |
| 2018-09-30 |
$-2.18 |
| 2018-06-30 |
$-2.58 |
| 2018-03-31 |
$-3.22 |
| 2017-12-31 |
$-4.42 |
| 2017-09-30 |
$-2.89 |
| 2017-06-30 |
$-3.46 |
| 2017-03-31 |
$-3.61 |
| 2016-12-31 |
$-4.84 |
| 2016-09-30 |
$-3.59 |
| 2016-06-30 |
$-3.14 |
| 2016-03-31 |
$-5.17 |
| 2015-12-31 |
$-3.69 |
| 2015-09-30 |
$-2.10 |
| 2015-06-30 |
$-1.99 |
| 2015-03-31 |
$-1.78 |
| 2014-12-31 |
$-0.84 |
| 2014-09-30 |
$-1.69 |
| 2014-06-30 |
$1.51 |
| 2014-03-31 |
$-12.61 |
| 2013-12-31 |
$-0.70 |
| 2013-09-30 |
$-1.65 |
| 2013-06-30 |
$-0.79 |
| 2013-03-31 |
$-0.62 |
| 2012-12-31 |
$-2.72 |
| 2012-09-30 |
$-1.86 |
| 2012-06-30 |
$-1.75 |
| 2012-03-31 |
$-1.03 |
